نتائج البحث

Efficacy and safety of HYYK formula for residual follicle revival in premature ovarian insufficiency: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

• Authors : Peng, Yin¹ (AUTHOR); Liu, Jian² (AUTHOR); Li, Yang¹ (AUTHOR)

Subjects: *CHINESE medicine; *OVARIAN follicle; *PATIENT safety

• Source: BMC Complementary Medicine & Therapies. 2/11/2025, Vol. 25 Issue 1, p1-9. 9p.

تفاصيل العنوان

The effects of diacylglycerol edible oil intervention in patients with chronic metabolic syndrome combined with asymptomatic hyperuricemia: study protocol for a multicenter, prospective, double-blind, randomized controlled trial.

• Authors : Li, Gui-yu¹ (AUTHOR) ; Zhu, Cui-feng² (AUTHOR) ; Huang, Zhao-qi³ (AUTHOR)

• Source: Trials. 1/13/2025, Vol. 26 Issue 1, p1-12. 12p.

تفاصيل العنوان

Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial.

• Authors : Ju Y; Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.; Mental Health Institute of Central South University, China National Technology Institute On Mental Disorders, Hunan Technology Institute of Psychiatry, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan, 410011, China.

Subjects: Depressive Disorder, Major*/Depressive Disorder, Major*/Depressive Disorder, Major*/drug therapy ; Acetamides*/Acetamides*/Acetamides*/therapeutic use ; Acetamides*/Acetamides*/Acetamides*/adverse effects

• Source: BMC medicine [BMC Med] 2025 Mar 05; Vol. 23 (1), pp. 137. Date of Electronic Publication: 2025 Mar 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 0 and 36 6  weeks of gestation: study protocol.

• Authors : Chawanpaiboon S; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand. .; Wutthigate P

Subjects: Dexamethasone*/Dexamethasone*/Dexamethasone*/administration & dosage ; Respiratory Distress Syndrome, Newborn*/Respiratory Distress Syndrome, Newborn*/Respiratory Distress Syndrome, Newborn*/prevention & control; Humans

• Source: Reproductive health [Reprod Health] 2025 Mar 03; Vol. 22 (1), pp. 30. Date of Electronic Publication: 2025 Mar 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101224380 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Efficacy and safety of ayurvedic intervention (Sarpgandha Mishran) vs amlodipine for Stage-I primary hypertension- study protocol for a prospective Double-Dummy, Double-Blind, placebo-controlled Randomized Clinical Trial.

• Authors : Yadav B; Central Council for Research in Ayurvedic Sciences, New Delhi, 110058, India.; Cardiovascular Research Laboratory, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India.

Subjects: Medicine, Ayurvedic* ; Amlodipine*/Amlodipine*/Amlodipine*/therapeutic use ; Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/therapeutic use

• Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2025 Mar 01; Vol. 25 (1), pp. 88. Date of Electronic Publication: 2025 Mar 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

The effect of royal jelly in oxidative stress, athletic performance, and mitochondrial biogenesis-related gene expression in endurance athletes: study protocol for a double-blind crossover trial.

• Authors : Miryan M; Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.; Nutritional Sciences Department, School of Nutritional Sciences and Food Technology, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Subjects: Cross-Over Studies* ; Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; Fatty Acids*

• Source: Trials [Trials] 2025 Feb 26; Vol. 26 (1), pp. 69. Date of Electronic Publication: 2025 Feb 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial.

• Authors : Yuan MQ; Senior Department of Infectious Diseases, The Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, No. 100 Western 4Th Ring Road, Beijing, 100039, China.; Medical School of Chinese PLA, Beijing, 100853, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/therapy ; Mesenchymal Stem Cell Transplantation*/Mesenchymal Stem Cell Transplantation*/Mesenchymal Stem Cell Transplantation*/methods ; SARS-CoV-2*

• Source: Stem cell research & therapy [Stem Cell Res Ther] 2025 Feb 25; Vol. 16 (1), pp. 94. Date of Electronic Publication: 2025 Feb 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101527581 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Effect of transcranial direct current stimulation on paroxysmal sympathetic hyperexcitability with acquired brain injury and cortical excitability: a randomized, double-blind, sham-controlled pilot study.

• Authors : Liu M; Department of Rehabilitation, Wangjing Hospital, China Academy of Chinese Medical Sciences, Huajiadijie, Chaoyang District, PO Box 100102, Beijing, China.; Li Y

Subjects: Transcranial Direct Current Stimulation*/Transcranial Direct Current Stimulation*/Transcranial Direct Current Stimulation*/methods ; Brain Injuries*/Brain Injuries*/Brain Injuries*/therapy ; Brain Injuries*/Brain Injuries*/Brain Injuries*/physiopathology

• Source: Journal of neuroengineering and rehabilitation [J Neuroeng Rehabil] 2025 Feb 25; Vol. 22 (1), pp. 35. Date of Electronic Publication: 2025 Feb 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101232233 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Effect of perioperative remote ischemic conditioning on myocardial injury in patients with unstable angina undergoing percutaneous coronary intervention: protocol of a multicenter, randomized, double-blind clinical trial.

• Authors : Xia L; Department of Rehabilitation Medicine, the First Affiliated Hospital of Nanjing Medical University, No.300 Guangzhou Road, Nanjing, 210029, China.; Yang Q

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/methods ; Angina, Unstable*/Angina, Unstable*/Angina, Unstable*/therapy

• Source: Trials [Trials] 2025 Feb 21; Vol. 26 (1), pp. 63. Date of Electronic Publication: 2025 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Additive effect of a single intravenous dose of acetaminophen administered at the end of laparoscopic hysterectomy on postoperative pain control with nefopam and fentanyl-based patient-controlled analgesia: a double-blind, randomized controlled trial.

• Authors : Nam S; Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Yoo S

Subjects: Pain, Postoperative*/Pain, Postoperative*/Pain, Postoperative*/drug therapy ; Pain, Postoperative*/Pain, Postoperative*/Pain, Postoperative*/prevention & control ; Nefopam*/Nefopam*/Nefopam*/administration & dosage

• Source: BMC anesthesiology [BMC Anesthesiol] 2025 Feb 20; Vol. 25 (1), pp. 88. Date of Electronic Publication: 2025 Feb 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100968535 Publication Model: Electronic Cited Medium:

تفاصيل العنوان